Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission

被引：0
|
作者：
Blad, William [1 ]
Whitley, Lisa [1 ]
Harrow, Paul [1 ]
机构：
[1] Univ Coll London Hosp, London, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.146
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P74
引用
收藏
页码：A87 / A88
页数：2
相关论文
共 50 条
  • [1] Risk of relapse after vedolizumab withdrawal in Inflammatory Bowel Disease for patients in histological remission
    Blad, W.
    Whitley, L.
    Harrow, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 942 - 942
  • [2] VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Papa, A.
    Ennas, S.
    Di Mario, C.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E99 - E100
  • [3] Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab
    Christensen, Britt
    Rubin, David T.
    Goeppinger, Sarah
    Colman, Ruben J.
    Yarur, Andres
    Hirsch, Ayal
    Bocheneck, Ashley
    Wichmann, Alana
    Sakuraba, Atsushi
    Cohen, Russell
    Siddiqui, Dania
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S783 - S784
  • [4] vedolizumab trough levels at week 6 and 14 correlate with clinical remission in inflammatory bowel disease patients
    Marino, M.
    Domenis, R.
    Biribin, L.
    Cifu, A.
    Navarria, L.
    Scardino, G.
    Fabris, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S492 - S492
  • [5] thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease
    Benitez, J. M.
    Garcia-Sanchez, V.
    Gisbert, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 494 - 495
  • [6] Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Di Mario, C.
    Papa, A.
    Gremese, E.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S398 - S398
  • [7] Effectiveness and safety of vedolizumab for the induction of remission in inflammatory bowel disease
    Chaparro, M.
    Sierra-Ausin, M.
    Mesonero, F.
    Maroto, N.
    Fernandez de Castro, C.
    Garcia-Sanchez, V.
    Lucendo, A. J.
    Busquets, D.
    Barreiro-de Acosta, M.
    Marin-Jimenez, I.
    Beltran, B.
    Ruiz Belmonte, L.
    Bermejo, F.
    Minguez, M.
    Pajares, R.
    Pineda, J. R.
    Sicilia, B.
    Martin-Rodriguez, D.
    Gutierrez, A.
    Rubio, S.
    Garcia Tercero, I.
    Piqueras, M.
    Ginard, D.
    Jucha, B.
    Munoz Villafranca, C.
    Martin-Arranz, M. D.
    Marti Romero, L.
    Fernandez Bonilla, E. M.
    Echarri, A.
    Forcelledo, J. F.
    Donday, M. G.
    Ramas, M.
    Gisbert, J. P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S416 - S417
  • [8] CLINICAL AND TRANSLATIONAL OUTCOMES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE RECEIVING VEDOLIZUMAB
    Williamson, Kate D.
    Slevin, Stephanie
    Willberg, Christian
    Chapman, Roger W.
    Klenerman, Paul
    Keshav, Satish
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1186 - S1187
  • [9] Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab
    Williamson, K. D.
    Slevin, S.
    Willberg, C.
    Chapman, R.
    Klenerman, P.
    Keshav, S.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S544 - S545
  • [10] Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission
    Parisio, Laura
    Settanni, Carlo Romano
    Varca, Simone
    Laterza, Lucrezia
    Lopetuso, Loris Riccardo
    Napolitano, Daniele
    Schiavoni, Elisa
    Turchini, Laura
    Fanali, Caterina
    Alfieri, Norma
    Pizzoferrato, Marco
    Papa, Alfredo
    Pafundi, Pia Clara
    Armuzzi, Alessandro
    Gasbarrini, Antonio
    Pugliese, Daniela
    Scaldaferri, Franco
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (04) : 452 - 459
12345